According to Benzinga Pro, Teva Pharmaceutical Indus's peer group average for short interest as a percentage of float is 3.58%, which means the company has less short interest than most of its peers.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and ...

Shopping for jeans online can be tricky, but we consulted with a celebrity stylist and creative directors from top denim ...

At close: May 29 at 5:24:55 PM GMT+3 ...

The Quarterly Growth Rate for Teva Pharmaceutical Industries Limited (TEVA ... Therefore, when observing Quarterly Growth Rate trends, if anomalies are shown in the chart, we encourage investors to ...

Operating Margin Target: 30% by 2027. Net Savings Target: $700 million by 2027. Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported its ninth consecutive quarter of growth, with revenue up 5% ...

Teva outlines acceleration path into a leading biopharma company Innovative medicines franchise on track to exceed $5 billion by 2030, led by AUSTEDO ® (deutetrabenazine), AJOVY ® (fremanezumab ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced results from a study of treatment patterns among patients with tardive dyskinesia ...

With Teva entering the next stage of its sweeping restructuring plan, thousands of employees are slated to be let go from the hybrid generics and innovative medicines giant. As part of a new bid ...